Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations
– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland, Nov. 6, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality ingredients from...
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications - BASEL, Switzerland, Oct. 29, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader...